Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)
This study has been terminated.
Study NCT00286169 Information provided by Sumitomo Dainippon Pharma Co., Ltd.
First Received on February 1, 2006. Last Updated on August 9, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Small-cell Lung Cancer
Additional conditions recognized in this trial
Small Cell Lung Carcinoma
More general conditions related to this trial
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Sumitomo Dainippon Pharma Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers